Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/120567
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMartínez Mármol, Ramón-
dc.contributor.authorStyrczewska, Katarzyna-
dc.contributor.authorPérez Verdaguer, Mireia-
dc.contributor.authorVallejo Gracia, Albert-
dc.contributor.authorComes i Beltrán, Núria-
dc.contributor.authorSorkin, Alexander-
dc.contributor.authorFelipe Campo, Antonio-
dc.date.accessioned2018-03-08T15:02:14Z-
dc.date.available2018-03-08T15:02:14Z-
dc.date.issued2017-02-10-
dc.identifier.issn2045-2322-
dc.identifier.urihttp://hdl.handle.net/2445/120567-
dc.description.abstractThe voltage-dependent potassium channel Kv1.3 plays essential physiological functions in the immune system. Kv1.3, regulating the membrane potential, facilitates downstream Ca2+ -dependent pathways and becomes concentrated in specific membrane microdomains that serve as signaling platforms. Increased and/or delocalized expression of the channel is observed at the onset of several autoimmune diseases. In this work, we show that adenosine (ADO), which is a potent endogenous modulator, stimulates PKC, thereby causing immunosuppression. PKC activation triggers down-regulation of Kv1.3 by inducing a clathrin-mediated endocytic event that targets the channel to lysosomal-degradative compartments. Therefore, the abundance of Kv1.3 at the cell surface decreases, which is clearly compatible with an effective anti-inflammatory response. This mechanism requires ubiquitination of Kv1.3, catalyzed by the E3 ubiquitin-ligase Nedd4-2. Postsynaptic density protein 95 (PSD-95), a member of the MAGUK family, recruits Kv1.3 into lipid-raft microdomains and protects the channel against ubiquitination and endocytosis. Therefore, the Kv1.3/PSD-95 association fine-tunes the anti-inflammatory response in leukocytes. Because Kv1.3 is a promising multi-therapeutic target against human pathologies, our results have physiological relevance. In addition, this work elucidates the ADO-dependent PKC-mediated molecular mechanism that triggers immunomodulation by targeting Kv1.3 in leukocytes.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/srep42395-
dc.relation.ispartofScientific Reports, 2017, vol. 7, num. 42395-
dc.relation.urihttps://doi.org/10.1038/srep42395-
dc.rightscc-by (c) Martínez Mármol, Ramón et al., 2017-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.sourceArticles publicats en revistes (Biomedicina)-
dc.subject.classificationSistema nerviós-
dc.subject.classificationUbiqüitina-
dc.subject.otherNervous system-
dc.subject.otherUbiquitin-
dc.titleUbiquitination mediates Kv1.3 endocytosis as a mechanism for protein Kinase C-dependent modulation-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec670571-
dc.date.updated2018-03-08T15:02:14Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid28186199-
Appears in Collections:Articles publicats en revistes (Institut de Biomedicina (IBUB))
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (Biomedicina)

Files in This Item:
File Description SizeFormat 
670571.pdf2.95 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons